These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 29357908)
1. Single and combined use of red cell distribution width, mean platelet volume, and cancer antigen 125 for differential diagnosis of ovarian cancer and benign ovarian tumors. Qin YY; Wu YY; Xian XY; Qin JQ; Lai ZF; Liao L; Lin FQ J Ovarian Res; 2018 Jan; 11(1):10. PubMed ID: 29357908 [TBL] [Abstract][Full Text] [Related]
2. Clinical application of red cell distribution width, mean platelet volume, and cancer antigen 125 detection in endometrial cancer. Zhang H; Liang K; Ke L; Tang S J Clin Lab Anal; 2020 Aug; 34(8):e23309. PubMed ID: 32196750 [TBL] [Abstract][Full Text] [Related]
3. The Clinical Application Value of RDW, CA153, and MPV in Breast Cancer. Lu F; Pan S; Qi Y; Li X; Wang J Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616344 [TBL] [Abstract][Full Text] [Related]
4. Can mean platelet volume and red blood cell distribution width show disease activity in rheumatoid arthritis? Tecer D; Sezgin M; Kanık A; İncel NA; Çimen ÖB; Biçer A; Şahin G Biomark Med; 2016 Sep; 10(9):967-74. PubMed ID: 27564580 [TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients. Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777 [TBL] [Abstract][Full Text] [Related]
6. The value of red cell distribution width in patients with ovarian cancer. Qin Y; Wang P; Huang Z; Huang G; Tang J; Guo Y; Huang P; Lai Z; Lin F Medicine (Baltimore); 2017 Apr; 96(17):e6752. PubMed ID: 28445301 [TBL] [Abstract][Full Text] [Related]
7. The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer. Cheng S; Han F; Wang Y; Xu Y; Qu T; Ju Y; Lu Z BMC Gastroenterol; 2017 Dec; 17(1):163. PubMed ID: 29262773 [TBL] [Abstract][Full Text] [Related]
8. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses. Lenhard M; Stieber P; Hertlein L; Kirschenhofer A; Fürst S; Mayr D; Nagel D; Hofmann K; Krocker K; Burges A Clin Chem Lab Med; 2011 Sep; 49(12):2081-8. PubMed ID: 21923475 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of simple blood counts as inflammation markers for brain tumor patients. Dagistan Y; Dagistan E; Citisli V Neurol Neurochir Pol; 2016; 50(4):231-5. PubMed ID: 27375135 [TBL] [Abstract][Full Text] [Related]
10. Mean platelet volume combined red cell distribution width as biomarker of chronic obstructive pulmonary disease with pulmonary heart disease. Bai Y; Tao XN Clin Respir J; 2020 Dec; 14(12):1122-1130. PubMed ID: 32772499 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases. Park Y; Lee JH; Hong DJ; Lee EY; Kim HS Clin Biochem; 2011 Jul; 44(10-11):884-8. PubMed ID: 21549107 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward? Azzam AZ; Hashad DI; Kamel NA Arch Gynecol Obstet; 2013 Jul; 288(1):167-72. PubMed ID: 23361457 [TBL] [Abstract][Full Text] [Related]
13. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy]. Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334 [TBL] [Abstract][Full Text] [Related]
14. Mean Platelet Volume, Red Cell Distribution Width, and Neutrophil-to-Lymphocyte Ratio Before and After Surgery in Patients With Carotid Body Tumors. Bozan N; Kocak ÖF; Dinc ME; Demir CY; Turan M; Kiroglu AF J Craniofac Surg; 2017 Oct; 28(7):e649-e653. PubMed ID: 28872499 [TBL] [Abstract][Full Text] [Related]
15. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients]. Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923 [TBL] [Abstract][Full Text] [Related]
16. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses. Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay. Horala A; Swiatly A; Matysiak J; Banach P; Nowak-Markwitz E; Kokot ZJ Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075407 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population. Kim YM; Whang DH; Park J; Kim SH; Lee SW; Park HA; Ha M; Choi KH Clin Chem Lab Med; 2011 Mar; 49(3):527-34. PubMed ID: 21320028 [TBL] [Abstract][Full Text] [Related]
19. Multiplexed bead-based immunoassay of four serum biomarkers for diagnosis of ovarian cancer. Kim YW; Bae SM; Kim IW; Liu HB; Bang HJ; Chaturvedi PK; Battogtokh G; Lim H; Ahn WS Oncol Rep; 2012 Aug; 28(2):585-91. PubMed ID: 22641176 [TBL] [Abstract][Full Text] [Related]
20. CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use. Duffy MJ; Bonfrer JM; Kulpa J; Rustin GJ; Soletormos G; Torre GC; Tuxen MK; Zwirner M Int J Gynecol Cancer; 2005; 15(5):679-91. PubMed ID: 16174214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]